Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Duncan Spalding

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 17, 2023
Serious complications of pancreatoduodenectomy correlate with lower rates of adjuvant chemotherapy: Results from the recurrence after Whipple's (RAW) studyThomas B Russell, Peter L Labib, Fabio Ausania, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|May 6, 2023
Predictors of actual five-year survival and recurrence after pancreatoduodenectomy for ampullary adenocarcinoma: results from an international multicentre retrospective cohort studyThomas B Russell, Peter L Labib, Jemimah Denson, et al.
Annals of Hepato-Biliary-Pancreatic Surgery|December 13, 2023
Do some patients receive unnecessary parenteral nutrition after pancreatoduodenectomy? Results from an international multicentre studyThomas B Russell, Peter L Labib, Paula Murphy, et al.
BJS Open|November 30, 2023
Postoperative complications after pancreatoduodenectomy for malignancy: results from the Recurrence After Whipple's (RAW) studyThomas B Russell, Peter L Labib, Jemimah Denson, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|May 16, 2024
Five-year recurrence/survival after pancreatoduodenectomy for pancreatic adenocarcinoma: does pre-existing diabetes matter? Results from the Recurrence After Whipple's (RAW) studyAshray Rajagopalan, Somaiah Aroori, Thomas B Russell, et al.
Annals of Hepato-Biliary-Pancreatic Surgery|September 4, 2023
Does an extensive diagnostic workup for upfront resectable pancreatic cancer result in a delay which affects survival? Results from an international multicentre studyThomas B Russell, Peter L Labib, Jemimah Denson, et al.
Cancer Cell|June 14, 2017
Kupffer Cell-Derived Tnf Triggers Cholangiocellular Tumorigenesis through JNK due to Chronic Mitochondrial Dysfunction and ROSDetian Yuan, Shan Huang, Emanuel Berger, et al.
Cancers|April 14, 2025
Venous Resection During Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma-A Multicentre Propensity Score Matching Analysis of the Recurrence After Whipple's (RAW) StudyRuben Bellotti, Somaiah Aroori, Benno Cardini, et al.
Cell Reports. Medicine|April 1, 2025
TIMEPOINT, a phase 1 study combining MTL-CEBPA with pembrolizumab, supports the immunomodulatory effect of MTL-CEBPA in solid tumorsRuth Plummer, Mikael H Sodergren, Rose Hodgson, et al.
Cancer Cell|February 1, 2026
Kupffer Cell-Derived Tnf Triggers Cholangiocellular Tumorigenesis through JNK due to Chronic Mitochondrial Dysfunction and ROSDetian Yuan, Shan Huang, Emanuel Berger, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 17, 2023
Serious complications of pancreatoduodenectomy correlate with lower rates of adjuvant chemotherapy: Results from the recurrence after Whipple's (RAW) studyThomas B Russell, Peter L Labib, Fabio Ausania, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|May 6, 2023
Predictors of actual five-year survival and recurrence after pancreatoduodenectomy for ampullary adenocarcinoma: results from an international multicentre retrospective cohort studyThomas B Russell, Peter L Labib, Jemimah Denson, et al.
Annals of Hepato-Biliary-Pancreatic Surgery|December 13, 2023
Do some patients receive unnecessary parenteral nutrition after pancreatoduodenectomy? Results from an international multicentre studyThomas B Russell, Peter L Labib, Paula Murphy, et al.
BJS Open|November 30, 2023
Postoperative complications after pancreatoduodenectomy for malignancy: results from the Recurrence After Whipple's (RAW) studyThomas B Russell, Peter L Labib, Jemimah Denson, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|May 16, 2024
Five-year recurrence/survival after pancreatoduodenectomy for pancreatic adenocarcinoma: does pre-existing diabetes matter? Results from the Recurrence After Whipple's (RAW) studyAshray Rajagopalan, Somaiah Aroori, Thomas B Russell, et al.
Annals of Hepato-Biliary-Pancreatic Surgery|September 4, 2023
Does an extensive diagnostic workup for upfront resectable pancreatic cancer result in a delay which affects survival? Results from an international multicentre studyThomas B Russell, Peter L Labib, Jemimah Denson, et al.
Cancer Cell|June 14, 2017
Kupffer Cell-Derived Tnf Triggers Cholangiocellular Tumorigenesis through JNK due to Chronic Mitochondrial Dysfunction and ROSDetian Yuan, Shan Huang, Emanuel Berger, et al.
Cancers|April 14, 2025
Venous Resection During Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma-A Multicentre Propensity Score Matching Analysis of the Recurrence After Whipple's (RAW) StudyRuben Bellotti, Somaiah Aroori, Benno Cardini, et al.
Cell Reports. Medicine|April 1, 2025
TIMEPOINT, a phase 1 study combining MTL-CEBPA with pembrolizumab, supports the immunomodulatory effect of MTL-CEBPA in solid tumorsRuth Plummer, Mikael H Sodergren, Rose Hodgson, et al.
Cancer Cell|February 1, 2026
Kupffer Cell-Derived Tnf Triggers Cholangiocellular Tumorigenesis through JNK due to Chronic Mitochondrial Dysfunction and ROSDetian Yuan, Shan Huang, Emanuel Berger, et al.
Pageof 6